Antiepileptic drugs prescription rates in other parts of the world
| Country (Ref) | Year | Patients (n) | Poly% | Prevalence* | VPA % | CBZ % | PHT % | PBT % | LTG % | TPM % | LEV % | OXC % | Others (%) |
| Jordan41 | 2014 | 694 | 33 | – | 51 | 33 | 4 | 3 | 3 | 4 | 1 | – | |
| Cuba42 | 2009 | 923 | 6 | 52 | 37 | 52 | 4 | 5 | 1 | 1 | – | – | CZP,(3) ETX (0.4) |
| Hong Kong10 | 2005–2009 | – | – | 21† | 58/36 | 32/30 | 3/3 | 7/8 | 8/7 | 7/7 | 2/7 | 1/3 | CLB (12/14), ETX (0.3/0.5), VGB (2/2), GBP (2/1) |
| Singapore11 | 2000–2009 | – | 37 | – | 40/38 | 23/27 | 3/4 | 29/13 | 3/2 | 0/3 | 0/6 | – | VGB (1/1) |
| South Korea15 | 2007 | – | 24 | 32 | – | – | – | 16 | 17 | – | 18 | – | |
| Taiwan8 | 2003–2007 | – | – | 138† | 12/7 | 7/6 | 2/1 | 65/24 | 19/10 | 21/9 | 0/18 | 29/9 | VGB (44/36), GBP (2/1) |
| USA14 | 1999–2006 | 4666 | 27 | – | 46 | 29 | 13 | 8 | 15 | 16 | 8 | 28 | GBP,(11) ETX,(5) ZNS,(3) TGB(1) |
Data for empty cells unavailable. Data before and after slash represent the earliest and most recent data for the study.
*Prevalence per 10 000 persons.
†Prevalence in the final year of study.
CBZ, carbamazepine; CLB, clobazam; CZP, clonazepam; ETX, ethosuximide; GBP, gabapentin; LEV, levetiracetam; LTG, lamotrigine; OXC, oxcarbazepine; PBT, phenobarbital; PHT, phenytoin; poly%, percentage polytherapy; STM, sulthiame; TGB, tiagabine; TPM, topiramate; VGB, vigabatrin; VPA, sodium valproate; ZNS, zonisamide.